Raffa Wealth Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$101 Hold
5
– – ﹤0.01% 1384
2026
Q2
$87 Buy
5
+4
+400% +$55 ﹤0.01% 1414
2026
Q1
$12 Buy
+1
New +$13 ﹤0.01% 1501

Other funds holding AMRX

Raffa Wealth Management's AMRX Position: Q3 2026 in Review

Raffa Wealth Management held its Amneal Pharmaceuticals (AMRX) position steady in Q3 2026 at 5 shares worth $101. The position accounts for ﹤0.01% of the portfolio, ranked #1384.

Raffa Wealth Management first reported a position in AMRX in Q1 2026 and has held it in 3 quarters since. 334 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • Raffa Wealth Management held 5 shares of Amneal Pharmaceuticals worth $101 as of Q3 2026.
  • Raffa Wealth Management left its Amneal Pharmaceuticals share count unchanged in Q3 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of Raffa Wealth Management's portfolio in Q3 2026, its #1384 holding.
  • Raffa Wealth Management first reported a position in Amneal Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 334 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on Raffa Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.